Acceleron Pharma Inc. buy marge
Start price
21.06.15
/
50%
€27.02
Target price
21.12.15
€32.00
Performance (%)
49.03%
End price
21.12.15
€40.27
Summary
This prediction ended on 21.12.15 with a price of €40.27. The BUY prediction by marge for Acceleron Pharma Inc. saw massive gains of 49.03%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acceleron Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by marge for this prediction
In the thread Acceleron Pharma Inc. diskutieren
Acceleron Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)